Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
1.470
-0.100 (-6.37%)
At close: Apr 7, 2026, 4:00 PM EDT
1.520
+0.050 (3.40%)
After-hours: Apr 7, 2026, 7:59 PM EDT
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $56.95 million as of April 7, 2026. Its market cap has decreased by -64.41% in one year.
Market Cap
56.95M
Enterprise Value
-58.92M
1-Year Change
-64.41%
Ranking
Category
Stock Price
$1.47
Market Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $56.95M, a decrease of -75.78%. That is a compound annual growth rate of -34.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 60.83M | -20.01% |
| Dec 31, 2025 | 76.05M | -59.43% |
| Dec 31, 2024 | 187.44M | 71.66% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.59M | 2.33% |
| Nov 15, 2022 | 235.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Impact BioMedical | 63.68M |
| Actuate Therapeutics | 58.80M |
| Entera Bio | 58.74M |
| OnKure Therapeutics | 58.66M |
| ImmuCell | 58.26M |
| TScan Therapeutics | 57.47M |
| MindWalk Holdings | 56.62M |
| ImageneBio | 55.59M |